YB2 Stock Overview
An investment holding company, engages in lottery business in the People’s Republic of China and Hong Kong. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Sinopharm Tech Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.014 |
| 52 Week High | HK$0.018 |
| 52 Week Low | HK$0.01 |
| Beta | 1.18 |
| 1 Month Change | -26.09% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 12.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| YB2 | DE Hospitality | DE Market | |
|---|---|---|---|
| 7D | 0% | -5.8% | -2.6% |
| 1Y | n/a | 18.7% | 6.9% |
Return vs Industry: Insufficient data to determine how YB2 performed against the German Hospitality industry.
Return vs Market: Insufficient data to determine how YB2 performed against the German Market.
Price Volatility
| YB2 volatility | |
|---|---|
| YB2 Average Weekly Movement | n/a |
| Hospitality Industry Average Movement | 4.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: YB2's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine YB2's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 19 | n/a | www.sinopharmtech.com.hk |
Sinopharm Tech Holdings Limited, an investment holding company, engages in lottery business in the People’s Republic of China and Hong Kong. It operates through Provision of Lottery-Related Services, Provision of Internet Plus Services, and Manufacturing and Distribution of Personal Protective Equipment segments. The company offers lottery-related hardware and software systems.
Sinopharm Tech Holdings Limited Fundamentals Summary
| YB2 fundamental statistics | |
|---|---|
| Market cap | €3.21m |
| Earnings (TTM) | -€1.28m |
| Revenue (TTM) | €5.16m |
0.6x
P/S Ratio-2.4x
P/E RatioIs YB2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YB2 income statement (TTM) | |
|---|---|
| Revenue | HK$42.84m |
| Cost of Revenue | HK$37.37m |
| Gross Profit | HK$5.47m |
| Other Expenses | HK$16.11m |
| Earnings | -HK$10.63m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.058 |
| Gross Margin | 12.77% |
| Net Profit Margin | -24.83% |
| Debt/Equity Ratio | 0% |
How did YB2 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/10/09 09:44 |
| End of Day Share Price | 2023/09/13 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2023/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sinopharm Tech Holdings Limited is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hoi Yin Yip | Everbright Securities International (HK) Limited (“EBSIHK”) |
| Hua He | Industrial Securities (HK) Financial Holdings |